Explore the complete record of transactions filed by Leach Jacob Steven, Chief Technology Officer. Director active across 2 companies, notably DEXCOM INC. Aggregated, 11 disclosures have been recorded. Total volume traded: €25.7m. The latest transaction was filed on 8 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Jacob Steven Leach is the EVP Chief Technology Officer and Director at Dexcom Inc and SenesTech, Inc. He is responsible for technology strategy and innovation within these companies. His role is essential in guiding strategic decisions and ensuring technological performance.